课题基金 / 基金详情

Development of New Anticancer Agents with New Pharmacological Mechanism

Development of New Anticancer Agents with New Pharmacological Mechanism
具有新药理机制的新型抗癌药物的开发
批准号:
11672118
负责人:
MIKAMI Yoshihiro
金额:
$1.73万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

MIKAMI Yoshihiro的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Previously, we have found that an acylated cholestane glycoside (XDSW-1) isolated from the bulbs of Ornithogalum saundersiae showed potent cytotoxic and cytostatic activities against various human malignant tumor cells. In a continuation, we evaluated cytotoxic activity of OSW-1 derivatives against HL-60 human leukemia cells and revealed the structure-activity relationships. The cytotoxicity of steroidal saponins were also examined. The results are as follows.1) A total of 24 OSW-1 derivatives, 19 of which were isolated from the bulbs of O. saundersiae, O. thyrsoides, and Galtonia candicans, and 5 of which were chemically synthesized, were evaluated for their cytotoxic activity against HL-60 cells, leading to the new findings of the structure-activity relationships of the OSW-1 related compounds. The role of the acylated diglycoside group attached at C-16 of the aglycon for the appearance of the potent cytotoxicity has not been revealed, and we consider that the assignment of the role … More would finally lead the development of a new anticancer agent with new pharmacological mechanism.2) Two new cholestane glycosides, named galtonioside A (1) and candicanosoide A (2), were isolated from G, candicans and their structures were formulated by spectroscopic and chemical methods. Compounds 1 and 2 showed strong cytotoxic activity against HL-60 cells, which was as potent as the clinically applied anticancer agents, etoposide and methotrexate. In the Jpn. Fdn. for Cancer Res. 38 cell line assay, 1 and 2 displayed differential cytotoxicities, with breast cancer, CNS cancer, and lung cancer subpanel cell lines showing particular sensitivity but with colon cancer, ovarian cancer, and stomach cancer subpanel cell lines being relatively resistant to them. The pattern of differential cytotoxicity of 1 and 2 was evaluated by Compare Program and was revealed not to be correlated with that shown by any of the other compounds including currently used anticancer drugs (correlation coefficient value is about 0.5). This indicates that 1 and 2 may have a unique mode of action and the potentiality as the leads of new anticancer agents.3) The cytotoxic activities of the steroidal saponins mainly isolated from the Liliaceae plants against HL-60 cells were examined. Some steroidal saponins evaluated showed considerable cytotoxic activities, which were almost as potent as that of etoposide used as a positive control. The activities were found to be sensitive to the monosaccharides constituting the sugar moieties and their sequences, as well as to the structures of the aglycons. " Less
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Mimaki Yoshihiro: "Cytotoxic activities and structure-cytotoxic relationships of steroidal saponins"Biol. Pharm. Bull.. 24. 1286-1289 (2001)
Mimaki Yoshihiro:“甾体皂苷的细胞毒性活性和结构-细胞毒性关系”Biol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mimaki Yoshihiro: "Flavonol glycosides and steroidal saponins from the leaves of Cestrum nocturnum and their cytotoxicity."J.Nat.Prod. 64(1). 17-22 (2001)
Mimaki Yoshihiro:“来自 Cestrum nocturnum 叶子的黄酮醇糖苷和甾体皂苷及其细胞毒性。”J.Nat.Prod。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kuroda Minpei: "Cholestane glycosides from the bulbs of Galtonia candicans and their cytotoxicity."Chem.Pham.Bull. 49(8). 1042-1046 (2001)
Kuroda Minpei:“来自 Galtonia candicans 球茎的胆甾烷糖苷及其细胞毒性。”Chem.Pham.Bull。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S. Furuya, F. Takayama, Y. Mimaki, et al.: "Cytotoxic Activity of Saponins from Camassia leichtlinii against Human Oral Tumor Cell Lines"Anticancer Res.. 21・2A. 959-964 (2001)
S.Furuya、F.Takayama、Y.Mimaki 等:“Camassia leichtlinii 皂苷对人口腔肿瘤细胞系的细胞毒性活性”Anticancer Res.. 21・2A (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Development of New Target-Based Anticancer Agents from Higher Plants